lapatinib/letrozole regimen
Term · Oncology and biomedicine · MLC-T-ONC-014714
A regimen consisting of lapatinib and letrozole that is used as a treatment for breast cancer.
| Identifier | MLC-T-ONC-014714 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | lapatinib-letrozole; Tykerb/Femara; lapatinib + letrozole; lapatinib plus letrozole; lapatinib-letrozole regimen |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014714",
"term": "lapatinib/letrozole regimen",
"field": "Oncology and biomedicine",
"definition": "A regimen consisting of lapatinib and letrozole that is used as a treatment for breast cancer.",
"synonyms": [
"lapatinib-letrozole",
"Tykerb/Femara",
"lapatinib + letrozole",
"lapatinib plus letrozole",
"lapatinib-letrozole regimen"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lapatinib-letrozole-regimen/"
}
Record 9,923 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.